Michael Cunyuan Chen
CIK: 0002127529
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SPTX
Seaport Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Chen Michael Cunyuan
Chen Michael Cunyuan (SEC CIK 0002127529) files insider reports with the SEC as Chief Scientific Officer of Seaport Therapeutics, Inc. (SPTX).
Signal8 holds 1 ownership filing by Chen Michael Cunyuan, a Form 4, filed on May 4, 2026. Those filings report 2 transactions, from Apr 30, 2026 to May 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Chen Michael Cunyuan's filings is in BOSTON, MA.
Recent filings by Chen Michael Cunyuan
Other insiders filing for Seaport Therapeutics, Inc. (SPTX)
- HOMBACH ROBERT J., Director
- GAP Coinvestments CDA, L.P., Director
- General Atlantic (SP), L.P., Director
- PureTech Health plc, 10% Owner
- Zohar Daphne, Chief Executive Officer
- HEALY JAMES, Director